title: [Status of gastrectomy in the multi-modality therapy concept of primary non-Hodgkin's lymphoma of the stomach].
abstract: Retrospectively analyzed data of 41 patients with gastric non-Hodgkin lymphoma are presented with special regard to the required extent of gastric resection in multimodality treatment. Thirty lymphomas of low, 2 of intermediate and 9 of high grade malignancy were distributed on stage Ie in 44%, stage IIe in 15%, stage IIIe in 12% and stage IV in 29%. The cumulative 5 years survival rate was 85% for stage Ie and 55% for the stages IIe and IIIe. Stage IV showed a 3 years survival of 10%. The proximal part of the stomach was involved in 73%, polycentric lesions were found in 15%. The majority (71%) of the tumours showed an infiltrating growth, an invasion of the oesophagus and/or the duodenum was seen in 20%. Five patients (12%) had synchronous adenocarcinoma as second gastric tumour. Regarding our morphological and topographical data curative surgery for primary gastric lymphoma required total gastric resection.
authors.affiliation: Chirurgische Klinik A, Heinrich-Heine-Universität, Düsseldorf.
authors.forename: P R
authors.initials: PR
authors.lastname: Verreet
authors.forename: F
authors.initials: F
authors.lastname: Borchard
authors.forename: H
authors.initials: H
authors.lastname: Stöltzing
authors.forename: K
authors.initials: K
authors.lastname: Thon
authors.forename: H D
authors.initials: HD
authors.lastname: Röher
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D008207:Lymphatic Metastasis; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
vernacular_title: Stellenwert der Gastrektomie im multimodalen Therapiekonzept des primären Non-Hodgkin-Lymphoms des Magens.